These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1363346

  • 1. HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer.
    Bacus SS, Chin DM, Stern RK, Ortiz R, Ruby SG, Weinberg DS.
    Anal Quant Cytol Histol; 1992 Dec; 14(6):433-45. PubMed ID: 1363346
    [Abstract] [Full Text] [Related]

  • 2. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS, Bacus JW, Slamon DJ, Press MF.
    Arch Pathol Lab Med; 1990 Feb; 114(2):164-9. PubMed ID: 1967930
    [Abstract] [Full Text] [Related]

  • 3. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 4. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

  • 5. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 6. Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.
    van Diest PJ, Baak JP, Chin D, Theeuwes JW, Bacus SS.
    Anal Cell Pathol; 1991 Jul; 3(4):195-202. PubMed ID: 1679345
    [Abstract] [Full Text] [Related]

  • 7. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 8. Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers.
    Moe RE, Moe KS, Porter P, Gown AM, Ellis G, Tapper D.
    Am J Surg; 1991 May; 161(5):580-3. PubMed ID: 1674411
    [Abstract] [Full Text] [Related]

  • 9. HER-2/neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma.
    Danova M, Giordano M, Torelli F, Franchini G, Cappellano F, Riccardi A, Catanzaro F, Mazzini G.
    Eur J Histochem; 1992 May; 36(3):279-88. PubMed ID: 1281010
    [Abstract] [Full Text] [Related]

  • 10. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI, Glukhova EI, Zhukova LG, Ermilova VD, Bogatyrev VN, Baryshnikov AIu.
    Arkh Patol; 2003 May; 65(5):25-9. PubMed ID: 14664144
    [Abstract] [Full Text] [Related]

  • 11. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.
    Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL.
    Anticancer Res; 1992 May; 12(6B):1965-71. PubMed ID: 1363511
    [Abstract] [Full Text] [Related]

  • 12. [Quantitative cytochemical analysis of T1 breast cancer].
    Ikeda N, Hirano T, Okuzawa K, Uchida O, Katsumi T, Kajiwara N, Hara E, Miura H, Kawate N, Konaka C.
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):821-3. PubMed ID: 8098199
    [Abstract] [Full Text] [Related]

  • 13. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
    Peredo R, Sastre G, Serrano J, Hunter Mellado R.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1025-32. PubMed ID: 11785652
    [Abstract] [Full Text] [Related]

  • 14. Breast cancer heterogeneity: evaluation of clonality in primary and metastatic lesions.
    Symmans WF, Liu J, Knowles DM, Inghirami G.
    Hum Pathol; 1995 Feb; 26(2):210-6. PubMed ID: 7860051
    [Abstract] [Full Text] [Related]

  • 15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 16. Amplification of HER-2(erbB-2/neu) oncogene as the most significant prognostic factor in a group of Russian breast cancer patients.
    Imyanitov EN, Chernitsa OI, Serova OM, Nikoforova IF, Pluzhnikova GF, Knyazev PG.
    Neoplasma; 1993 Oct 15; 40(1):35-9. PubMed ID: 7688867
    [Abstract] [Full Text] [Related]

  • 17. Cell proliferation, nuclear ploidy, and EGFr and HER2/neu tyrosine kinase oncoproteins in infiltrating ductal breast carcinoma.
    Fernández Val JF, Losada J, Arregui Murua MA, Sarría R.
    Cancer Genet Cytogenet; 2002 Oct 01; 138(1):69-72. PubMed ID: 12419588
    [Abstract] [Full Text] [Related]

  • 18. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
    Ciampa A, Xu B, Ayata G, Baiyee D, Wallace J, Wertheimer M, Edmiston K, Khan A.
    Appl Immunohistochem Mol Morphol; 2006 Jun 01; 14(2):132-7. PubMed ID: 16785779
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F, Núñez MJ, Piqueras V, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2002 Jun 01; 22(1A):295-8. PubMed ID: 12017306
    [Abstract] [Full Text] [Related]

  • 20. Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma.
    Midulla C, Giovagnoli MR, Valli C, Vecchione A.
    Anal Quant Cytol Histol; 1995 Jun 01; 17(3):157-62. PubMed ID: 7546049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.